[1] Sundar S, Chakravarty J. Antimony toxicity. Int J Environ Res Public Health, 2010; 7, 4267−77.
[2] Höck A, Demmel U, Schicha H, et al. Trace element concentration in human brain: activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain, 1975; 98, 49−64.
[3] Tanu T, Anjum A, Jahan M, et al. Antimony-induced neurobehavioral and biochemical perturbations in mice. Biol Trace Elem Res, 2018; 186, 199−207.
[4] Wang XK, Zhu PY, Xu SY, et al. Antimony, a novel nerve poison, triggers neuronal autophagic death via reactive oxygen species-mediated inhibition of the protein kinase B/mammalian target of rapamycin pathway. Int J Biochem Cell Biol, 2019; 114, 105561.
[5] Mao JM, Yang JB, Zhang Y, et al. Arsenic trioxide mediates HAPI microglia inflammatory response and subsequent neuron apoptosis through p38/JNK MAPK/STAT3 pathway. Toxicol Appl Pharmacol, 2016; 303, 79−89.
[6] Phuagkhaopong S, Ospondpant D, Kasemsuk T, et al. Cadmium-induced IL-6 and IL-8 expression and release from astrocytes are mediated by MAPK and NF-κB pathways. Neurotoxicology, 2017; 60, 82−91.
[7] Maiuolo J, Macrì R, Bava I, et al. Myelin disturbances produced by sub-toxic concentration of heavy metals: the role of oligodendrocyte dysfunction. Int J Mol Sci, 2019; 20, 4554.
[8] Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol, 2015; 7, a020412.
[9] Blanco-Suárez E, Caldwell ALM, Allen NJ. Role of astrocyte-synapse interactions in CNS disorders. J Physiol, 2017; 595, 1903−16.
[10] Dossi E, Vasile F, Rouach N. Human astrocytes in the diseased brain. Brain Res Bull, 2018; 136, 139−56.
[11] Carter SF, Herholz K, Rosa-Neto P, et al. Astrocyte biomarkers in Alzheimer’s disease. Trends Mol Med, 2019; 25, 77−95.
[12] Jiao M, Yin KZ, Zhang T, et al. Effect of the SSeCKS-TRAF6 interaction on gastrodin-mediated protection against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced astrocyte activation and neuronal death. Chemosphere, 2019; 226, 678−86.
[13] Chen XX, Nie XK, Mao JM, et al. Perfluorooctane sulfonate mediates secretion of IL-1β through PI3K/AKT NF-кB pathway in astrocytes. Neurotoxicol Teratol, 2018; 67, 65−75.
[14] Guénette SY. Astrocytes: a cellular player in Aβ clearance and degradation. Trends Mol Med, 2003; 9, 279−80.
[15] Kondylis V, Kumari S, Vlantis K, Pasparakis M. The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation. Immunol Rev, 2017; 277, 113−27.
[16] Dresselhaus EC, Meffert MK. Cellular specificity of NF-κB function in the nervous system. Front Immunol, 2019; 10, 1043.
[17] Wan CH, Zhang Y, Jiang JK, et al. Critical role of TAK1-dependent nuclear factor-κB signaling in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced astrocyte activation and subsequent neuronal death. Neurochem Res, 2015; 40, 1220−31.
[18] Liu XH, Buffington JA, Tjalkens RB. NF-κB-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines. Mol Brain Res, 2005; 141, 39−47.
[19] Dieter MP, Jameson CW, Elwell MR, et al. Comparative toxicity and tissue distribution of antimony potassium tartrate in rats and mice dosed by drinking water or intraperitoneal injection. J Toxicol Environ Health, 1991; 34, 51−82.
[20] Zhao XY, Jin Y, Yang LJ, et al. Promotion of SIRT1 protein degradation and lower SIRT1 gene expression via reactive oxygen species is involved in Sb-induced apoptosis in BEAS-2b cells. Toxicol Lett, 2018; 296, 73−81.
[21] Zhao XY, Wu YF, Li JL, et al. JNK activation-mediated nuclear SIRT1 protein suppression contributes to silica nanoparticle-induced pulmonary damage via p53 acetylation and cytoplasmic localisation. Toxicology, 2019; 423, 42−53.
[22] Piccolini VM, Esposito A, Dal Bo V, et al. Cerebellum neurotransmission during postnatal development: [Pt(O,O'-acac)(γ-acac)(DMS)] vs. cisplatin and neurotoxicity. Int J Dev Neurosci, 2015; 40, 24−34.
[23] Baldin V, Lukas J, Marcote MJ, et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev, 1993; 7, 812−21.
[24] Dietrich DR. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol, 1993; 23, 77−109.
[25] Olabarria M, Goldman JE. Disorders of astrocytes: alexander disease as a model. Annu Rev Pathol, 2017; 12, 131−52.
[26] Oliveira LFG, Souza-Silva F, Cysne-Finkelstein L, et al. Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate. Biomed Res Int, 2017; 2017, 9840210.
[27] Saghazadeh A, Rezaei N. Systematic review and meta-analysis links autism and toxic metals and highlights the impact of country development status: higher blood and erythrocyte levels for mercury and lead, and higher hair antimony, cadmium, lead, and mercury. Prog Neuro-Psychopharmacol Biol Psychiatry, 2017; 79, 340−68.
[28] Gerhardsson L, Lundh T, Minthon L, et al. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord, 2008; 25, 508−15.
[29] Alimonti A, Ristori G, Giubilei F, et al. Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. NeuroToxicology, 2007; 28, 450−6.
[30] Burda JE, Bernstein AM, Sofroniew MV. Astrocyte roles in traumatic brain injury. Exp Neurol, 2016; 275, 305−15.
[31] Sofroniew MV. Astrogliosis. Cold Spring Harb Perspect Biol, 2014; 7, a020420.
[32] Brenner M. Role of GFAP in CNS injuries. Neurosci Lett, 2014; 565, 7−13.
[33] Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci, 2009; 32, 638−47.
[34] Mann KK, Davison K, Colombo M, et al. Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling. Toxicol Lett, 2006; 160, 158−70.
[35] Ge X, Zhang DM, Li MM, et al. Microglial LOX-1/MAPKs/NF-κB positive loop promotes the vicious cycle of neuroinflammation and neural injury. Int Immunopharmacol, 2019; 70, 187−200.
[36] Huang RR, Zhang Y, Han B, et al. Circular RNA HIPK2 regulates astrocyte activation via cooperation of autophagy and ER stress by targeting MIR124-2HG. Autophagy, 2017; 13, 1722−41.
[37] Han B, Zhang Y, Zhang YH, et al. Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke. Autophagy, 2018; 14, 1164−84.
[38] Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med, 2016; 22, 586−97.
[39] Zhang Y, Huang RR, Cheng MJ, et al. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2. Microbiome, 2019; 7, 116.
[40] Colombo E, Farina C. Astrocytes: key regulators of neuroinflammation. Trends Immunol, 2016; 37, 608−20.
[41] Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep, 2016; 13, 3391−96.
[42] Eddleston M, Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience, 1993; 54, 15−36.
[43] John GR, Lee SC, Brosnan CF. Cytokines: powerful regulators of glial cell activation. Neuroscientist, 2003; 9, 10−22.
[44] Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol, 2007; 28, 138−45.
[45] Min KJ, Yang MS, Kim SU, et al. Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J Neurosci, 2006; 26, 1880−7.
[46] Frost GR, Li YM. The role of astrocytes in amyloid production and Alzheimer's disease. Open Biol, 2017; 7, 170228.
[47] Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol, 2010; 119, 7−35.
[48] Vargas MR, Johnson DA, Sirkis DW, et al. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci, 2008; 28, 13574−81.
[49] Chen YM, Vartiainen NE, Ying WH, et al. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem, 2001; 77, 1601−10.